Banco De Sabadell, S.A Eli Lilly & CO Transaction History

Banco De Sabadell, S.A

$133 Million
Q3 2024

A detailed history of Banco De Sabadell, S.A transactions in Eli Lilly & CO stock. As of the latest transaction made, Banco De Sabadell, S.A holds 4,390 shares of LLY stock, worth $3.4 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares

4,390

Previous 4,533 3.15%

Holding current value

$3.4 Million

Previous $4.1 Million 5.29%

% of portfolio

2.91%

Previous 3.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $110,416 - $137,282	-143 Reduced 3.15%	4,390 $3.89 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $63,788 - $79,995	-88 Reduced 1.9%	4,533 $4.1 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $170,553 - $228,176	-288 Reduced 5.87%	4,621 $3.6 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $38,864 - $45,815	-74 Reduced 1.49%	4,909 $2.86 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $166,055 - $228,932	-382 Reduced 7.12%	4,983 $2.68 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $471,394 - $630,309	-1,344 Reduced 20.03%	5,365 $2.51 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $140,094 - $164,533	451 Added 7.21%	6,709 $2.3 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $435,057 - $506,928	-1,353 Reduced 17.78%	6,258 $2.29 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $27,869 - $31,759	94 Added 1.25%	7,611 $2.46 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $370,153 - $434,614	-1,328 Reduced 15.01%	7,517 $2.44 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $95,284 - $118,413	406 Added 4.81%	8,845 $2.53 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $269,370 - $334,289	1,198 Added 16.54%	8,439 $2.33 Million
Q3 2021 Nov 04, 2021	SELL	$221.6 - $272.71 $11,966 - $14,726	-54 Reduced 0.74%	7,241 $1.68 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $5.74 Million - $7.42 Million	-31,789 Reduced 81.34%	7,295 $1.67 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $2.75 Million - $3.57 Million	16,766 Added 75.12%	39,084 $7.28 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $392,293 - $519,098	-3,007 Reduced 11.87%	22,318 $3.75 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $1.7 Million - $1.96 Million	-11,612 Reduced 31.44%	25,325 $3.74 Million
Q2 2020 Aug 07, 2020	BUY	$136.42 - $164.18 $3.98 Million - $4.8 Million	29,209 Added 377.96%	36,937 $6.04 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $123,692 - $153,096	-1,039 Reduced 11.85%	7,728 $1.07 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $29,509 - $36,550	-276 Reduced 3.05%	8,767 $1.15 Million
Q3 2019 Nov 15, 2019	SELL	$106.79 - $116.16 $1.02 Million - $1.11 Million	-9,517 Reduced 51.28%	9,043 $1.01 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $19,609 - $22,889	-177 Reduced 0.94%	18,560 $2.06 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $127,449 - $150,017	-1,145 Reduced 5.76%	18,737 $2.43 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $1.47 Million - $1.65 Million	-13,928 Reduced 41.19%	19,882 $2.27 Million
Q3 2018 Nov 16, 2018	SELL	$85.86 - $107.31 $304,287 - $380,306	-3,544 Reduced 9.49%	33,810 $3.62 Million
Q2 2018 Aug 15, 2018	BUY	$75.7 - $86.88 $1.53 Million - $1.76 Million	20,271 Added 118.66%	37,354 $3.19 Million
Q1 2018 May 16, 2018	BUY	$74.21 - $87.6 $101,816 - $120,187	1,372 Added 8.73%	17,083 $1.32 Million
Q4 2017 Feb 16, 2018	BUY	$81.94 - $87.89 $1.29 Million - $1.38 Million	15,711	15,711 $1.33 Million

Others Institutions Holding LLY

# of Institutions

4,012

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $735B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.

Account

Banco De Sabadell, S.A Eli Lilly & CO Transaction History